Target type: cellularcomponent
A protein complex which is capable of peptidase activity. [GO_REF:0000088, GOC:bhm, GOC:TermGenie, PMID:1689240]
Peptidase complexes are multi-protein assemblies that play crucial roles in a wide range of cellular processes, including protein degradation, signal transduction, and regulation of gene expression. These complexes are characterized by their ability to cleave peptide bonds within proteins, a process known as proteolysis. The composition and organization of peptidase complexes vary greatly, depending on the specific function and cellular context. However, they often share common features, such as the presence of catalytic subunits responsible for proteolytic activity and regulatory subunits that control complex assembly, substrate specificity, and activity. The cellular component of a peptidase complex can be described as a dynamic and intricate network of proteins, often localized to specific cellular compartments, where they interact and cooperate to achieve their biological functions. These complexes are essential for maintaining cellular homeostasis and respond to various stimuli, enabling cells to adapt to changing conditions. Specific examples of peptidase complexes include the proteasome, a large multi-subunit complex involved in protein degradation, and the signal peptidase complex, which cleaves signal peptides from newly synthesized proteins.'
"
Protein | Definition | Taxonomy |
---|---|---|
Prolyl endopeptidase FAP | A prolyl endopeptidase FAP that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q12884] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
n-carbobenzoxyglycyl-prolyl-4-methylcoumarinyl amide | N-carbobenzoxyglycyl-prolyl-4-methylcoumarinyl amide: fluorogenic substrate for post-proline cleaving enzyme | ||
sitagliptin | sitagliptin : A triazolopyrazine that exhibits hypoglycemic activity. | triazolopyrazine; trifluorobenzene | EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; environmental contaminant; hypoglycemic agent; serine proteinase inhibitor; xenobiotic |
vildagliptin | amino acid amide | ||
talabostat | talabostat: an antineoplastic agent; structure in first source | ||
linagliptin | linagliptin : A xanthine that is 7H-xanthine bearing (4-methylquinazolin-2-yl)methyl, methyl, but-2-yn-1-yl and 3-aminopiperidin-1-yl substituents at positions 1, 3, 7 and 8 respectively (the R-enantiomer). Used for treatment of type II diabetes. Linagliptin: A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS. | aminopiperidine; quinazolines | EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; hypoglycemic agent |
kyp 2047 | |||
bms 477118 | adamantanes; azabicycloalkane; monocarboxylic acid amide; nitrile; tertiary alcohol | EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; hypoglycemic agent | |
alogliptin | alogliptin : A piperidine that is 3-methyl-2,4-dioxo-3,4-dihydropyrimidine carrying additional 2-cyanobenzyl and 3-aminopiperidin-1-yl groups at positions 1 and 2 respectively (the R-enantiomer). Used in the form of its benzoate salt for treatment of type 2 diabetes. alogliptin: structure in first source | nitrile; piperidines; primary amino compound; pyrimidines | EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; hypoglycemic agent |
gosogliptin | amino acid amide | ||
anagliptin | anagliptin: anagliptin hydrochloride salt is the active compound | amino acid amide | |
mk-3102 | pyrrolopyrazole |